CV Sciences could make it to NASDAQ

691 0

The success of the company this year is giving it strength to move up

Cannabis company CV Sciences has already gotten off to a good start this year. It began to introduce new products last year and has recently been awarded certification by the U.S. Hemp Authority. Those actions have helped the company’s stock continue to impress investors, and CV now says it’s ready for the big time. It is rumored to be considering a move from the OTCQB exchange to NASDAQ.

Fueling the rumor is the announcement that CV Sciences has hired ICR, a top PR firm. ICR will lead the company’s investor and media relations, as well as its corporate communications. As one of the largest PR firms in the U.S., it has offices throughout the country, including in New York, San Francisco, San Diego, Boston, Norwalk and Baltimore.

According to CV Sciences CEO Joseph Dowling, “CV Sciences experienced significant growth in 2018 and we are well positioned to continue to accelerate our growth in 2019 and beyond as we execute our business strategy, expand our retail and e-commerce distribution, and bring innovative branded CBD products to market. ICR’s capital markets and financial media expertise, combined with its significant experience in the nutritional supplement, cannabis, CPG and retail sectors will enhance our communications to all of our stakeholders, broaden exposure to institutional investors, and deepen the financial communities’ understanding of CV Sciences’ differentiated business model, growth strategy and market opportunity. We are excited to partner with ICR as we enter this next chapter of growth for our Company and the hemp-based CBD market.”

While no official announcement has been made of a bid for a NASDAQ move, all the pieces are coming together to make for a clear picture. It’s now not a question of if the company will be listed on the exchange, but when.